More than 8 Results
Display change
TOPICS

MD Anderson and TOPPAN Holdings announce strategic alliance to co-develop organoid technology for evaluating cancer treatments

• 3D cell culture technology may allow researchers to rapidly test a variety of treatments directly on patient biopsies• Teams will evaluate technology as clinical tool for personalized cancer therapy• Collaboration will aim to obtain CAP/CLIA certification of organoid-based assay, followed by clinical studies in multiple indications